C07K 2319/23
Containing a gst-tag
Official title: containing a GST-tag
C07K2319/23 (Containing a gst-tag) appears on 357 US grants and 434 published applications in this corpus.
Search patents in C07K- Granted patents
- 357
- Published applications
- 434
- Assignees
- 305
- Inventors
- 950
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 17 | 0 |
| 1999 | 10 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 1 |
| 2002 | 9 | 20 |
| 2003 | 5 | 11 |
| 2004 | 4 | 9 |
| 2005 | 10 | 23 |
| 2006 | 9 | 10 |
| 2007 | 7 | 16 |
| 2008 | 2 | 6 |
| 2009 | 6 | 17 |
| 2010 | 14 | 17 |
| 2011 | 11 | 10 |
| 2012 | 8 | 30 |
| 2013 | 10 | 18 |
| 2014 | 15 | 29 |
| 2015 | 21 | 25 |
| 2016 | 23 | 25 |
| 2017 | 16 | 26 |
| 2018 | 18 | 30 |
| 2019 | 15 | 13 |
| 2020 | 17 | 22 |
| 2021 | 14 | 19 |
| 2022 | 16 | 17 |
| 2023 | 6 | 12 |
| 2024 | 14 | 16 |
| 2025 | 6 | 7 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered cells secreting therapeutic enzymes18 Aug 2026US 12,709,739 B2Cartesian Therapeutics, Inc.
- Cell penetrating peptide24 Feb 2026US 12,559,522 B2Astellas Pharma Inc.
- CGAS/DNCV-like nucleotidyltransferases and uses thereof10 Feb 2026US 12,545,900 B2Dana-Farber Cancer Institute, Inc.
- Methods for producing proteins9 Dec 2025US 12,492,232 B2South Australian Health and Medical Research Institute Limited
- Methods for identifying anti clostridial neurotoxin compounds9 Dec 2025US 12,493,036 B2State of Israel, Israel Institute for Biological Research
- Collagen production method8 Oct 2026US 2026/0308236 A1UniBio Corporation
- New high expression and high activity n-glycosidases, methods of production and applications thereof8 Oct 2026US 2026/0308562 A1Centre National de la Recherche Scientifique (CNRS)
- Method for producing block copolymer or aqueous dispersion containing same, adhesive, coating liquid, coating agent, or molded body13 Aug 2026US 2026/0234344 A1Spiber Inc.
- Multivalent proteins and screening methods5 Feb 2026US 2026/0036590 A1Valink Therapeutics Ltd
- Transgenic cory15 Jan 2026US 2026/0015388 A1GloFish, LLC
Most cited
By later US patents
- Method of isolation and purification of fusion polypeptides138US 5,532,142 ABoard of Regents, The University of Texas System · 1996
- Association peptides132US 5,491,074 AAffymax Technologies N.V. · 1996
- Recombinant toxin fragments113US 6,461,617 B1Microbiological Research Authority · 2002
- Engineered protein kinases which can utilize modified nucleotide triphosphate substrates92US 6,390,821 B1Princeton University · 2002
- Engineered protein kinases which can utilize nucleotide triphosphate substrates85US 7,026,461 B1Princeton University · 2006